News
Sanofi said it will invest at least $20 billion in the US through 2030, joining other pharmaceutical companies boosting their ...
A district court ruled that the HHS does have the power to review drug manufacturers’ plans to pay hospitals rebates instead ...
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a multi-year ...
France's finance minister criticised on Thursday a decision by French drugmaker Sanofi to invest at least $20 billion in the ...
Sanofi plans to invest $20 billion in U.S.-based drug R&D and manufacturing over five years, creating jobs and boosting ...
Add Sanofi to the list of drugmakers committing billions to bolster their operations in the United States as President Donald ...
Access to diabetes care in lower-income countries still lags for children, despite efforts from insulin makers.
The French drugmaker joined several peers in promising new investments in U.S. drug production, but cautioned plans could ...
Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...
3h
The Bangkok Post on MSNSanofi Hosts Regional Webinar on Protecting High-Risk Groups from Seasonal InfluenzaThe symposium highlighted the disproportionate impact of seasonal influenza on high-risk groups, particularly adults aged 65 ...
Sanofi plans to invest at least $20 billion in the United States through 2030 to boost manufacturing and research, joining ...
France's finance minister criticised on Thursday a decision by French drugmaker Sanofi to invest at least $20 billion in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results